Global Drug Eluting Stent Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Drug Eluting Stent Industry In 2025?

The market for drug-eluting stents has experienced significant expansion recently, projected to advance from a value of $7.63 billion in 2024 to $8.26 billion the subsequent year, reflecting a compound annual growth rate (CAGR) of 8.3%. This upward trajectory during the past period is underpinned by several factors, including the demand for superior therapeutic alternatives, supportive clinical data, official endorsements, evolving healthcare financial considerations, and established clinical protocols and guidance.

Projected for robust expansion in the coming years, the market encompassing drug-eluting stents anticipates reaching a valuation of $11.07 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.6%; this upward trajectory during the forecast timeframe is fundamentally driven by demographic shifts toward an older populace and the increasing prevalence of long-term illnesses, alongside broader access facilitated by evolving healthcare coverage frameworks, the venturing into new territories globally, and a rising focus on patient-centric treatment modalities, while key developments shaping this period involve customized medical treatments, less invasive procedural approaches, advancements in pioneering health technologies, and the introduction of newer drug delivery systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

Which Major Market Drivers Are Shaping The Future Of The Drug Eluting Stent Market?

Increasing prevalence of coronary heart disease is anticipated to fuel the expansion of the drug-eluting stent sector in the future. This condition, characterized by the narrowing or obstruction of coronary arteries due to plaque accumulation, carries the risk of serious outcomes like myocardial infarction or angina pectoris. Factors such as increasingly inactive lifestyles, substandard dietary habits, the aging demographic, and greater public consciousness contribute to the heightened incidence of coronary heart disease. Drug-eluting stents prove beneficial in managing coronary heart disease by mechanically restoring flow in constricted or closed arteries and administering drugs designed to inhibit subsequent narrowing, known as restenosis. To illustrate the trend, data from the Centers for Disease Control and Prevention, a US government entity, showed that the proportion of adults aged 18 and above affected by coronary heart disease rose from 4.6% in 2020 to 4.9% in 2022, as reported in May 2024, suggesting the growing caseload will drive the drug-eluting stent market forward.

What Are The Major Segment Types Covered In The Drug Eluting Stent Market?

The drug eluting stentmarket covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free

2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs

3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds

4) By Application: Coronary Diseases, Peripheral Vascular Diseases

5) By End-User: Hospitals, Specialty Clinic

Subsegments:

1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents

2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents

What Trends Are Redefining The Drug Eluting Stent Market Dynamics?

Within the arena of drug-eluting stents, firms are concentrating efforts on engineering novel deployment mechanisms, like the dual-layer balloon design, aspiring to elevate patient prognoses and propel progress in interventional cardiac procedures. This dual-layer balloon technology integrated into a drug-eluting stent apparatus sharpens the accuracy of both medicament dispersal and stent placement by affording superior manageability and consistent drug coating onto the vessel lining.Specifically, in August of 2022, Medtronic Plc, an Irish medical device manufacturer, introduced Onyx Frontier; this represents the most recent iteration of coronary drug-eluting stent systems engineered to build upon the immediate efficacy and clinical evidence established by its predecessor, the Resolute Onyx DES. Embodying the identical leading stent architecture found in the Resolute Onyx, the Onyx Frontier DES offers an extensive range of sizes, catering to patient vessels spanning from 2.0mm to 5.0mm in diameter. Significant structural augmentations characterize the Onyx Frontier DES, including an innovative dual-layer balloon, a lessened profile for navigating tight spaces, and enhanced catheter pliability, ultimately resulting in a 16 percent boost in the ease of delivery compared to the former Resolute Onyx DES generation, all maintained without compromising inherent radial force.

Which Key Players Are Driving Competition In The Drug Eluting Stent Market?

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

What Regional Growth Trends Are Shaping The Drug Eluting Stent Market Outlook?

North America was the largest region in the drug-eluting stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Drug Eluting Stent Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15557&type=smp

Browse Through More Reports Similar to the Global Drug Eluting Stent Market 2025, By The Business Research Company

Drug Eluting Balloons Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795